The Science

Professor Claude M. Wischik, co-founder and Executive Chairman of TauRx Therapeutics, along with colleagues at the University of Aberdeen, has devoted nearly 30 years to investigating the structure and role of tau tangles in the development of Alzheimer’s, frontotemporal dementia (FTD) and other neurodegenerative diseases. They are the original discoverers of the composition of the tau protein pathology in Alzheimer’s.